ABO Blood Group and the Risk of Hepatocellular Carcinoma: A Case-Control Study in Patients with Chronic Hepatitis B

• Qiang Li ,

  Contributed equally to this work with: Qiang Li, Cui-Hua Yu

  Affiliation Division of Liver Disease, Jinan Infectious Disease Hospital, Shandong University, Jinan, China

  ⨯
• Cui-Hua Yu ,

  Contributed equally to this work with: Qiang Li, Cui-Hua Yu

  Affiliation Department of Pharmacy, Jinan Infectious Disease Hospital, Shandong University, Jinan, China

  ⨯
• Jin-Hong Yu,

  Affiliation Division of Liver Disease, Jinan Infectious Disease Hospital, Shandong University, Jinan, China

  ⨯
• Li Liu,

  Affiliation Division of Liver Disease, Jinan Infectious Disease Hospital, Shandong University, Jinan, China

  ⨯
• Shuang-Shuang Xie,

  Affiliation Division of Liver Disease, Jinan Infectious Disease Hospital, Shandong University, Jinan, China

  ⨯
• Wen-Wen Li,

  Affiliation Unit of Disease Control Genome Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan

  ⨯
• Xia Yang,

  Affiliation Unit of Hyperbaric Medicine, Shandong Province Hospital, Jinan, China

  ⨯
• Wen-Bo Fan,

  Affiliation Unit of Digestive Disease, Department of Internal Medicine, Qihe People's Hospital, Shandong, China

  ⨯
• Zhong-Tao Gai ,

  * E-mail: hepatology65@yahoo.com.cn (S-JC); mailto:gaizhongtao@sina.com (Z-TG)

  Affiliation Department of Infectious Disease, Jinan Infectious Disease Hospital, Shandong University, Jinan, China

  ⨯
• Shi-Jun Chen ,

  * E-mail: hepatology65@yahoo.com.cn (S-JC); mailto:gaizhongtao@sina.com (Z-TG)

  Affiliation Division of Liver Disease, Jinan Infectious Disease Hospital, Shandong University, Jinan, China

  ⨯
• Naoya Kato

  Affiliation Unit of Disease Control Genome Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan

  ⨯